Venture capital for companies developing innovative therapeutics

Our Team

We are driven by the quest for new and better medicines.

Innovative Drug Development

Be invested in an attractive growth market.

BB Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats.

BB Pureos Bioventures strives to impact patients’ lives by advancing innovative treatments for severe diseases.

We are driven by the quest for new and better medicines

Our Portfolio

Our companies develop innovative medicines.

Latest News

We are happy to share our latest progress.

September 2020

Pureos Bioventures closes first fund with USD 170 mn

September 2020

NovaGo Therapeutics appoints Ian Metcalfe as CEO

September 2020

Pureos invests in EUR 71 million financing of LAVA Therapeutics

Member of